nifedipine has been researched along with Lupus Erythematosus, Systemic in 15 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of hypertension in systemic lupus erythematosus (SLE) may be complicated by unwanted immunologic vascular and renal side effects of drugs." | 5.27 | Nifedipine in the treatment of hypertension in systemic lupus erythematosus. ( Bursztyn, M; Many, A; Rosenthal, T, 1987) |
| "Long-acting nifedipine tablets were given to 47 severely and moderately hypertensive patients with renal insufficiency, cardiovascular, cerebrovascular, and peripheral vascular disease, diabetes mellitus, asthma, and systemic lupus erythematosus." | 3.67 | Long-acting nifedipine in moderate and severe hypertensive patients with serious concomitant diseases. ( Bursztyn, M; Grossman, E; Rosenthal, T, 1985) |
| "Treatment of hypertension in systemic lupus erythematosus (SLE) may be complicated by unwanted immunologic vascular and renal side effects of drugs." | 1.27 | Nifedipine in the treatment of hypertension in systemic lupus erythematosus. ( Bursztyn, M; Many, A; Rosenthal, T, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nkeck, JR | 1 |
| Endomba, FTA | 1 |
| Ndoadoumgue, AL | 1 |
| Kalbassou, FB | 1 |
| Bari, A | 1 |
| Zeeshan, F | 1 |
| Hanif, G | 1 |
| Jabeen, U | 1 |
| Bano, I | 1 |
| Rathore, AW | 1 |
| Lu, MC | 1 |
| Lai, NS | 1 |
| Yu, HC | 1 |
| Hsieh, SC | 1 |
| Tung, CH | 1 |
| Yu, CL | 1 |
| Sachetto, Z | 1 |
| Fernandes, SR | 1 |
| Del Rio, AP | 1 |
| Coimbra, IB | 1 |
| Bértolo, MB | 1 |
| Costallat, LT | 1 |
| Katayama, A | 1 |
| Otsuka, F | 1 |
| Tanabe, K | 1 |
| Tsukamoto, N | 1 |
| Yamanaka, R | 1 |
| Matsumoto, Y | 1 |
| Nasu, Y | 1 |
| Makino, H | 1 |
| Rodenas, M | 1 |
| Kumar, S | 1 |
| Freund, KB | 1 |
| Moallem, J | 1 |
| Hauser, D | 1 |
| Pokroy, R | 1 |
| Bukelman, A | 1 |
| Katz, H | 1 |
| Pollack, A | 1 |
| Kahan, A | 1 |
| Weber, S | 1 |
| Amor, B | 1 |
| Menkes, CJ | 1 |
| Saporta, L | 1 |
| Hodara, M | 1 |
| Guerin, F | 1 |
| Degeorges, M | 1 |
| Miller, FW | 1 |
| Santoro, TJ | 1 |
| Machet, L | 1 |
| Callens, A | 1 |
| Machet, MC | 1 |
| Desveaux, B | 1 |
| Vaillant, L | 1 |
| Guseva, NG | 1 |
| Poltyrev, AS | 1 |
| Alekseev, VI | 1 |
| Anikina, NV | 1 |
| Shcherbakov, AB | 1 |
| Bursztyn, M | 2 |
| Many, A | 1 |
| Rosenthal, T | 2 |
| Wigley, FM | 1 |
| Malamet, R | 1 |
| Wise, RA | 1 |
| Grossman, E | 1 |
| Gladman, DD | 1 |
| Sternberg, L | 1 |
3 trials available for nifedipine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Calcium entry blocking agents in digital vasospasm (Raynaud's phenomenon).
Topics: Adult; Arthritis, Rheumatoid; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Metho | 1983 |
[Correction of microcirculatory disorders in rheumatic diseases].
Topics: Administration, Oral; Clinical Trials as Topic; Dextrans; Dipyridamole; Disseminated Intravascular C | 1985 |
Reproducibility of cold provocation in patients with Raynaud's phenomenon.
Topics: Adult; Cold Temperature; Double-Blind Method; Female; Fingers; Humans; Imidazoles; Lupus Erythematos | 1987 |
12 other studies available for nifedipine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Gangrene of All Digits and Toes Attributable to Systemic Lupus Erythematosus With Negative Antiphospholipid Antibodies.
Topics: Adult; Amputation, Surgical; Antibodies, Antiphospholipid; Aspirin; Female; Fingers; Follow-Up Studi | 2019 |
A Rare Case of Kikuchi-Fujimoto Disease Associated with Systemic Lupus Erythematosus.
Topics: Adolescent; Asian People; Fever; Histiocytic Necrotizing Lymphadenitis; Humans; Lupus Erythematosus, | 2018 |
Nifedipine suppresses Th1/Th2 cytokine production and increased apoptosis of anti-CD3 + anti-CD28-activated mononuclear cells from patients with systemic lupus erythematosus via calcineurin pathway.
Topics: Adaptor Proteins, Signal Transducing; Adult; Apoptosis; Calcineurin; Calcium Channel Blockers; Calci | 2008 |
Systemic lupus erythematosus associated with vasculitic syndrome (Takayasu's arteritis).
Topics: Adult; Amiodarone; Female; Humans; Lupus Erythematosus, Systemic; Nifedipine; Prednisone; Takayasu A | 2010 |
Unexpected occurrence of adrenal Cushing's syndrome in a patient with systemic lupus erythematosus.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Angiomyolipoma; Antihyperten | 2011 |
Retinitis preceding systemic lupus erythematosus in absence of anti-phospholipid antibodies.
Topics: Adolescent; Antibodies, Antiphospholipid; Atenolol; Cyclophosphamide; Diagnosis, Differential; Drug | 2012 |
Ocular ischemia associated with uncontrolled hypertension in lupus erythematosus.
Topics: Adult; Blood Pressure; Fluorescein Angiography; Humans; Hypertension; Ischemia; Lupus Erythematosus, | 2004 |
Nifedipine in the treatment of migraine headache and amaurosis fugax in patients with systemic lupus erythematosus.
Topics: Adult; Blindness; Female; Humans; Lupus Erythematosus, Systemic; Male; Migraine Disorders; Nifedipin | 1984 |
Pulmonary hypertension in systemic lupus erythematosus--treatment with high dose nifedipine therapy?
Topics: Adult; Female; Humans; Hypertension, Pulmonary; Lupus Erythematosus, Systemic; Nifedipine | 1993 |
Nifedipine in the treatment of hypertension in systemic lupus erythematosus.
Topics: Antibodies; Antibodies, Antinuclear; Blood Pressure; Complement System Proteins; DNA; Drug Evaluatio | 1987 |
Long-acting nifedipine in moderate and severe hypertensive patients with serious concomitant diseases.
Topics: Adult; Aged; Angina Pectoris; Asthma; Cerebrovascular Disorders; Diabetes Complications; Edema; Fema | 1985 |
Pulmonary hypertension in systemic lupus erythematosus.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension, Pulmona | 1985 |